Serum Institute Of India Pvt. Ltd.

This Phase 2 trial is testing a malaria vaccine that aims to both prevent infection and block the parasite from spreading to mosquitoes. Around 1,200 healthy participants aged 9 to 50 in Mali will receive either the R21 vaccine alone or a combination with Pfs230D1-CRM197, both wi…

This study looks at how well the MenFive (NmCV-5) meningitis vaccine still works more than five years after a single shot. Researchers will test the blood of 450 people in Mali and The Gambia who got the vaccine when they were 2 to 29 years old. The goal is to see if their immune…